AVITA Medical, Inc. Stock Australian S.E.
Equities
AVH
AU000000AVH4
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.77 AUD | +2.97% | -10.36% | -35.43% |
Apr. 17 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
Apr. 11 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Sales 2024 * | 115M 74.66M | Sales 2025 * | 165M 107M | Capitalization | 341M 222M |
---|---|---|---|---|---|
Net income 2024 * | -56M -36.42M | Net income 2025 * | -17M -11.06M | EV / Sales 2024 * | 2.8 x |
Net cash position 2024 * | 19.8M 12.87M | Net cash position 2025 * | 1.85M 1.21M | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
-6.41
x | P/E ratio 2025 * |
-34.7
x | Employees | 207 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on AVITA Medical, Inc.
1 day | +2.97% | ||
1 week | -10.36% | ||
Current month | -44.04% | ||
1 month | -44.38% | ||
3 months | -41.19% | ||
6 months | -13.71% | ||
Current year | -35.43% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2.77 | +2.97% | 281,858 |
24-04-23 | 2.69 | -3.24% | 545,617 |
24-04-22 | 2.78 | -0.71% | 567,535 |
24-04-19 | 2.8 | -5.08% | 714,835 |
24-04-18 | 2.95 | -4.53% | 687,270 |
Delayed Quote Australian S.E., April 24, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- RCEL Stock
- AVH Stock